Brian Groch

Brian brings 30+ years of senior experiencein healthcare and life science industries, including product commercialization,developing, and executing global sales strategies, business development, andoperations. Most recently, Brian served as President of Shield TherapeuticsInc. and Chief Commercial Officer of Shield Therapeutics Plc where he wasinstrumental in the raise of $45 million to successfully establish the USentity of Shield Therapeutics and launch their first pharmaceutical product,Accrufer. Prior to Shield, Brian served as Executive Vice President BusinessDevelopment and Chief Commercial Officer at Acasti Pharma Inc., abiopharmaceutical company developing innovative drugs for cardiometabolicdiseases. Prior to Acasti, Brian served as Executive Vice President and ChiefCommercial Officer of Veru Inc., a urology, oncology, and female healthproducts company, where he was responsible for leading the development andexecution of the company’s commercial strategy. Under his leadership, Veruexperienced rapid growth in sales of the Company’s women’s health product.Brian also served as Chief Commercial Officer for Telesta Therapeutics, wherehe led the development and implementation of the global commercial strategy,Previously, Brian served as Vice President of Commercial Operations and MarketAccess for Horizon, where he oversaw operations for the buildout of the orphanbusiness group. This included the integration of two acquisitions valued atover $1.9 billion. Brian also has held the position of Head of Market Accesswith Dendron and management roles with pharmaceutical giants Novartis and Merck& Co. He holds a M.S. in Healthcare Administration and Marketing fromCentral Michigan University as well as a B.S. in Physiology from CentralMichigan University.